POSTOPERATIVE PELVIC SEPSIS RATES FOLLOWING COMPLETE PATHOLOGIC RESPONSE TO NEOADJUVANT THERAPY IN RECTAL CANCER.

被引：0
|
作者：
Mihalicz, D.
Brar, M.
Datta, I.
MacLean, A.
Buie, W.
Schmocker, S.
Kennedy, E.
Heine, J.
机构：
来源：
DISEASES OF THE COLON & RECTUM | 2015年 / 58卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1411
引用
收藏
页码：E382 / E382
页数：1
相关论文
共 50 条
  • [31] Future directions in neoadjuvant therapy of rectal cancer: Maximizing pathological complete response rates
    Mohiuddin, Mohammed
    Mohiuddin, Majid M.
    Marks, John
    Marks, Gerald
    CANCER TREATMENT REVIEWS, 2009, 35 (07) : 547 - 552
  • [32] Rates of pathologic complete or near complete response following neoadjuvant chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer
    Chuong, Michael
    Mellon, Eric Albert
    Hoffe, Sarah
    Shridhar, Ravi
    Springett, Gregory M.
    Hodul, Pamela Joy
    Malafa, Mokenge Peter
    Figura, Nicholas
    Centeno, Barbara
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [33] Pathologic complete response rates following neoadjuvant chemotherapy in the treatment of locally advanced breast cancer
    Prabhudesai, S. R.
    Malini, A. V.
    Raghavendra, R. M.
    Ashwini, N. R.
    Geetha, V. P.
    Patil, S.
    Diwakar, R. B.
    Gopinath, K. S.
    Srinath, B. S.
    Raizada, N.
    Somorat, B.
    Naik, R.
    Giri, S. P.
    Ajaikumar, B. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [34] KRAS Mutation in Locally Advanced Rectal Cancer is Independently Associated with a Lower Rate of Pathologic Complete Response Following Neoadjuvant Therapy
    Chow, O. S.
    Kuk, D.
    Keskin, M.
    Smith, J. J.
    Ordonez, N.
    Pelossof, R.
    Chen, C.
    Chen, Z.
    Avila, K.
    Nash, G.
    Temple, L. K.
    Weiser, M.
    Guillem, J. G.
    Paty, P. B.
    Berger, M.
    Patil, S.
    Garcia-Aguilar, J.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S18 - S18
  • [35] Tumor Volume as Predictor of Pathologic Complete Response Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer
    Lutsyk, Myroslav
    Awawda, Muhammad
    Gourevich, Konstantin
    Ben Yosef, Rahamim
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (09): : 482 - 486
  • [36] METFORMIN INCREASES COMPLETE PATHOLOGIC RESPONSE AMONG DIABETICS WITH RECTAL CANCER.
    Maguire, L.
    Jensen, C.
    Kwaan, M.
    Madoff, R.
    Melton, G.
    Gaertner, W.
    DISEASES OF THE COLON & RECTUM, 2017, 60 (06) : E357 - E358
  • [37] Near-complete response following neoadjuvant therapy in rectal cancer: resect now?
    Perez, Rodrigo O.
    Cerdan-Santacruz, Carlos
    Juliao, Guilherme P. Sao
    BRITISH JOURNAL OF SURGERY, 2023, 110 (08) : 936 - 937
  • [38] OUTCOMES OF NONSURGICAL TREATMENT IN PATIENTS WITH CLINICAL COMPLETE RESPONSE AFTER NEOADJUVANT THERAPY FOR RECTAL CANCER.
    Cotti, G.
    Nahas, C.
    Marques, C.
    Imperiale, A.
    Ribeiro Junior, U.
    Nahas, S.
    Cecconello, I.
    Hoff, P.
    DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E262 - E262
  • [39] The Predictors of Complete Pathologic Response in Rectal Cancer during the Total Neoadjuvant Therapy Era: A Systematic Review
    Flom, Emily
    Schultz, Kurt S.
    Pantel, Haddon J.
    Leeds, Ira L.
    CANCERS, 2023, 15 (24)
  • [40] Distance to the Anal Verge Is Associated With Pathologic Complete Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer
    Patel, Sunil V.
    Roxburgh, Campbell S.
    Vakiani, Efsevia
    Shia, Jinru
    Smith, J. Joshua
    Temple, Larissa K.
    Paty, Philip
    Garcia-Aguilar, Julio
    Nash, Garrett
    Guillem, Jose
    Wu, Abraham
    Reyngold, Marsha
    Weiser, Martin R.
    JOURNAL OF SURGICAL ONCOLOGY, 2016, 114 (05) : 637 - 641
12345